MDxHealth, the Belgium-based molecular diagnostics company, has announced the appointment of a new scientific advisory board to assist management in the development of the company’s current pipelines in the field of personalised cancer treatment.
The new members of the board are Jonathan I. Epstein, professor of urologic pathology, oncology and surgical pathology at Johns Hopkins University School of Medicine, and director of the Genitourinary Pathology Consult Service; James G. Herman, professor of oncology-cancer biology at Johns Hopkins Medical Institutions; Gerrit A. Meijer, professor of pathology at the Free University Medical Center, in Amsterdam, and Eric M. Wallen, associate professor of surgery at the University of North Carolina Medical Center.
Copyright 2011 Evernow Publishing Ltd